-
An P, Winkler C, Guan L, O'Brien SJ, Zeng Z, Consortium HBVS, 2011: A common HLA-DPA1 variant is a major determinant of hepatitis B virus clearance in Han Chinese[J]. J Infect Dis, 203, 943-947. doi: 10.1093/infdis/jiq154
-
Arnold W, Hess G, Meyer zum Buschenfelde KH, Kosters W, Biswas R, Strauch M, Knolle J, 1976: Simultaneous occurrence in the serum of hepatitis B surface antigen (HBsAg) and antibodies against HBsAg (Anti-HBs) of different subtypes (Serologic and fluorescence histologic studies)[J]. Verh Dtsch Ges Inn Med, 82, 405-407.
-
Betts K, Abusleme L, Freeman AF, Sarmadi M, Fahle G, Pittaluga S, Cuellar-Rodriguez J, Hickstein D, Holland SM, Su H, Moutsopoulos NM, 2015: A 17-year old patient with DOCK8 deficiency, severe oral HSV-1 and aggressive periodontitis - a case of virally induced periodontitis?[J]. J Clin Virol, 63, 46-50. doi: 10.1016/j.jcv.2014.12.003
-
Boztug H, Karitnig-Weiss C, Ausserer B, Renner ED, Albert MH, Sawalle-Belohradsky J, Belohradsky BH, Mann G, Horcher E, Rummele-Waibel A, Geyeregger R, Lakatos K, Peters C, Lawitschka A, Matthes-Martin S, 2012: Clinical and immunological correction of DOCK8 deficiency by allogeneic hematopoietic stem cell transplantation following a reduced toxicity conditioning regimen[J]. Pediatr Hematol Oncol, 29, 585-594. doi: 10.3109/08880018.2012.714844
-
Chang SW, Fann CS, Su WH, Wang YC, Weng CC, Yu CJ, Hsu CL, Hsieh AR, Chien RN, Chu CM, Tai DI, 2014: A genome-wide association study on chronic HBV infection and its clinical progression in male Han-Taiwanese[J]. PLoS ONE, 9, e99724-. doi: 10.1371/journal.pone.0099724
-
Chen Y, Qian F, Yuan Q, Li X, Wu W, Guo X, Li L, 2011: Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs[J]. J Clin Virol, 52, 198-203. doi: 10.1016/j.jcv.2011.07.011
-
Chisari FV, Isogawa M, Wieland SF, 2010: Pathogenesis of hepatitis B virus infection[J]. Pathol Biol (Paris), 58, 258-266. doi: 10.1016/j.patbio.2009.11.001
-
Colson P, Borentain P, Motte A, Henry M, Moal V, Botta-Fridlund D, Tamalet C, Gerolami R, 2007: Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers[J]. Virology, 367, 30-40. doi: 10.1016/j.virol.2007.05.012
-
Cote JF, Vuori K, 2002: Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity[J]. J Cell Sci, 115, 4901-4913. doi: 10.1242/jcs.00219
-
Diepolder HM, Jung MC, Keller E, Schraut W, Gerlach JT, Gruner N, Zachoval R, Hoffmann RM, Schirren CA, Scholz S, Pape GR, 1998: A vigorous virus-specific CD4 + T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B[J]. Clin Exp Immunol, 113, 244-251. doi: 10.1046/j.1365-2249.1998.00665.x
-
Ding F, Miao XL, Li YX, Dai JF, Yu HG, 2016: Mutations in the S gene and in the overlapping reverse transcriptase region in chronic hepatitis B Chinese patients with coexistence of HBsAg and anti-HBs[J]. Braz J Infect Dis, 20, 1-7. doi: 10.1016/j.bjid.2015.08.014
-
Fu X, Chen J, Chen H, Lin J, Xun Z, Li S, Liu C, Zeng Y, Chen T, Yang B, Ou Q, 2017: Mutation in the S gene of hepatitis B virus and anti-HBs subtype-nonspecificity contributed to the co-existence of HBsAg and anti-HBs in patients with chronic hepatitis B virus infection[J]. J Med Virol, 89, 1419-1426. doi: 10.1002/jmv.24782
-
Griffin TJ, Hall JG, Prudent JR, Smith LM, 1999: Direct genetic analysis by matrix-assisted laser desorption/ionization mass spectrometry[J]. Proc Natl Acad Sci USA, 96, 6301-6306. doi: 10.1073/pnas.96.11.6301
-
Hadiji-Abbes N, Mihoubi W, Martin M, Karakasyan-Dia C, Frikha F, Gergely C, Jouenne T, Gargouri A, Mokdad-Gargouri R, 2015: Characterization of C69R variant HBsAg: effect on binding to anti-HBs and the structure of virus-like particles[J]. Arch Virol, 160, 2427-2433. doi: 10.1007/s00705-015-2515-y
-
Harada Y, Tanaka Y, Terasawa M, Pieczyk M, Habiro K, Katakai T, Hanawa-Suetsugu K, Kukimoto-Niino M, Nishizaki T, Shirouzu M, Duan X, Uruno T, Nishikimi A, Sanematsu F, Yokoyama S, Stein JV, Kinashi T, Fukui Y, 2012: DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses[J]. Blood, 119, 4451-4461. doi: 10.1182/blood-2012-01-407098
-
Holotnakova T, Tylkova L, Takacova M, Kopacek J, Petrik J, Pastorekova S, Pastorek J, 2010: Role of the HBx oncoprotein in carbonic anhydrase 9 induction[J]. J Med Virol, 82, 32-40. doi: 10.1002/jmv.21671
-
Hoofnagle JH, Doo E, Liang TJ, Fleischer R, Lok AS, 2007: Management of hepatitis B: summary of a clinical research workshop[J]. Hepatology, 45, 1056-1075. doi: 10.1002/hep.21627
-
Hou JL, Lai W, 2015: The guideline of prevention and treatment for chronic hepatitis B: a 2015 update[J]. Zhonghua Gan Zang Bing Za Zhi, 23, 888-905.
-
Hu L, Zhai X, Liu J, Chu M, Pan S, Jiang J, Zhang Y, Wang H, Chen J, Shen H, Hu Z, 2012: Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development[J]. Hepatology, 55, 1426-1431. doi: 10.1002/hep.24799
-
Hua KT, Liu YF, Hsu CL, Cheng TY, Yang CY, Chang JS, Lee WJ, Hsiao M, Juan HF, Chien MH, Yang SF, 2017: 3′UTR polymorphisms of carbonic anhydrase Ⅸ determine the miR-34a targeting efficiency and prognosis of hepatocellular carcinoma[J]. Sci Rep, 7, 4466-. doi: 10.1038/s41598-017-04732-3
-
Hyuga S, Wada H, Eguchi H, Otsuru T, Iwgami Y, Yamada D, Noda T, Asaoka T, Kawamoto K, Gotoh K, Takeda Y, Tanemura M, Umeshita K, Doki Y, Mori M, 2017: Expression of carbonic anhydrase Ⅸ is associated with poor prognosis through regulation of the epithelialmesenchymal transition in hepatocellular carcinoma[J]. Int J Oncol, 51, 1179-1190. doi: 10.3892/ijo.2017.4098
-
Isogawa M, Robek MD, Furuichi Y, Chisari FV, 2005: Toll-like receptor signaling inhibits hepatitis B virus replication in vivo[J]. J Virol, 79, 7269-7272. doi: 10.1128/JVI.79.11.7269-7272.2005
-
Jabara HH, McDonald DR, Janssen E, Massaad MJ, Ramesh N, Borzutzky A, Rauter I, Benson H, Schneider L, Baxi S, Recher M, Notarangelo LD, Wakim R, Dbaibo G, Dasouki M, Al-Herz W, Barlan I, Baris S, Kutukculer N, Ochs HD, Plebani A, Kanariou M, Lefranc G, Reisli I, Fitzgerald KA, Golenbock D, Manis J, Keles S, Ceja R, Chatila TA, Geha RS, 2012: DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation[J]. Nat Immunol, 13, 612-620. doi: 10.1038/ni.2305
-
Kang HJ, Kim IH, Sung CO, Shim JH, Yu E, 2015: Expression of carbonic anhydrase 9 is a novel prognostic marker in resectable hepatocellular carcinoma[J]. Virchows Arch, 466, 403-413. doi: 10.1007/s00428-014-1709-0
-
Kao JH, Chen PJ, Lai MY, Chen DS, 2003: Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers[J]. Gastroenterology, 124, 327-334. doi: 10.1053/gast.2003.50053
-
Kearney CJ, Randall KL, Oliaro J, 2017: DOCK8 regulates signal transduction events to control immunity[J]. Cell Mol Immunol, 14, 406-411. doi: 10.1038/cmi.2017.9
-
Korachi M, Ceran N, Adaleti R, Nigdelioglu A, Sokmen M, 2013: An association study of functional polymorphic genes IRF-1, IFNGR-1, and IFN-gamma with disease progression, aspartate aminotransferase, alanine aminotransferase, and viral load in chronic hepatitis B and C[J]. Int J Infect Dis, 17, e44-49. doi: 10.1016/j.ijid.2012.08.004
-
Krishnaswamy JK, Singh A, Gowthaman U, Wu R, Gorrepati P, Sales Nascimento M, Gallman A, Liu D, Rhebergen AM, Calabro S, Xu L, Ranney P, Srivastava A, Ranson M, Gorham JD, McCaw Z, Kleeberger SR, Heinz LX, Muller AC, Bennett KL, Superti-Furga G, Henao-Mejia J, Sutterwala FS, Williams A, Flavell RA, Eisenbarth SC, 2015: Coincidental loss of DOCK8 function in NLRP10-deficient and C3H/HeJ mice results in defective dendritic cell migration[J]. Proc Natl Acad Sci USA, 112, 3056-3061. doi: 10.1073/pnas.1501554112
-
Kuang SY, Jackson PE, Wang JB, Lu PX, Munoz A, Qian GS, Kensler TW, Groopman JD, 2004: Specific mutations of hepatitis B virus in plasma predict liver cancer development[J]. Proc Natl Acad Sci USA, 101, 3575-3580. doi: 10.1073/pnas.0308232100
-
Lee S, Abecasis GR, Boehnke M, Lin X, 2014: Rare-variant association analysis: study designs and statistical tests[J]. Am J Hum Genet, 95, 5-23. doi: 10.1016/j.ajhg.2014.06.009
-
Li Y, Shi X, 2013: MicroRNAs in the regulation of TLR and RIG-I pathways[J]. Cell Mol Immunol, 10, 65-71. doi: 10.1038/cmi.2012.55
-
Li J, Lin S, Chen Q, Peng L, Zhai J, Liu Y, Yuan Z, 2010: Inhibition of hepatitis B virus replication by MyD88 involves accelerated degradation of pregenomic RNA and nuclear retention of pre-S/S RNAs[J]. J Virol, 84, 6387-6399. doi: 10.1128/JVI.00236-10
-
Lin Y, Gao ZX, Shen X, Chen MJ, Li YT, Li SL, Lin HL, Zhao QF, Liu F, Niu JJ, 2018: Correlation between polymorphisms in toll-like receptor genes and the activity of hepatitis B virus among treatment-naive patients: a case-control study in a Han Chinese population[J]. BMC Infect Dis, 18, 28-. doi: 10.1186/s12879-018-2943-x
-
Liu CJ, Chen BF, Chen PJ, Lai MY, Huang WL, Kao JH, Chen DS, 2006: Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers[J]. J Infect Dis, 193, 1258-1265. doi: 10.1086/502978
-
Mizesko MC, Banerjee PP, Monaco-Shawver L, Mace EM, Bernal WE, Sawalle-Belohradsky J, Belohradsky BH, Heinz V, Freeman AF, Sullivan KE, Holland SM, Torgerson TR, Al-Herz W, Chou J, Hanson IC, Albert MH, Geha RS, Renner ED, Orange JS, 2013: Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency[J]. J Allergy Clin Immunol, 131, 840-848. doi: 10.1016/j.jaci.2012.12.1568
-
Nishikimi A, Kukimoto-Niino M, Yokoyama S, Fukui Y, 2013: Immune regulatory functions of DOCK family proteins in health and disease[J]. Exp Cell Res, 319, 2343-2349. doi: 10.1016/j.yexcr.2013.07.024
-
Pei RJ, Chen XW, Lu MJ, 2014: Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways[J]. World J Gastroenterol, 20, 11618-11629. doi: 10.3748/wjg.v20.i33.11618
-
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC, 2007: PLINK: a tool set for whole-genome association and population-based linkage analyses[J]. Am J Hum Genet, 81, 559-575. doi: 10.1086/519795
-
Qi P, Chen YM, Wang H, Fang M, Ji Q, Zhao YP, Sun XJ, Liu Y, Gao CF, 2009: 509C > T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection[J]. Cancer Immunol Immunother, 58, 1433-1440. doi: 10.1007/s00262-009-0660-4
-
Saxena R, Chawla YK, Verma I, Kaur J, 2014: IL-6(-572/-597) polymorphism and expression in HBV disease chronicity in an Indian population[J]. Am J Hum Biol, 26, 549-555. doi: 10.1002/ajhb.22562
-
Shen HP, Hsiao YH, Yang SF, Liu YF, Ko JL, Wang PH, 2018: Single nucleotide polymorphisms and haplotypes of carbonic anhydrase 9 can predict invasive squamous cell carcinoma of uterine cervix[J]. Int J Med Sci, 15, 587-594. doi: 10.7150/ijms.23359
-
Shiraishi A, Uruno T, Sanematsu F, Ushijima M, Sakata D, Hara T, Fukui Y, 2017: DOCK8 protein regulates macrophage migration through Cdc42 protein activation and LRAP35a protein interaction[J]. J Biol Chem, 292, 2191-2202. doi: 10.1074/jbc.M116.736306
-
Sinai P, Nguyen C, Schatzle JD, Wulfing C, 2010: Transience in polarization of cytolytic effectors is required for efficient killing and controlled by Cdc42[J]. Proc Natl Acad Sci USA, 107, 11912-11917. doi: 10.1073/pnas.0913422107
-
Skol AD, Scott LJ, Abecasis GR, Boehnke M, 2006: Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies[J]. Nat Genet, 38, 209-213. doi: 10.1038/ng1706
-
Wang B, Wang J, Zheng Y, Zhou S, Zheng J, Wang F, Ma X, Zeng Z, Consortium HBVS, 2010: A study of TNF-alpha-238 and -308 polymorphisms with different outcomes of persistent hepatitis B virus infection in China[J]. Pathology, 42, 674-680.
-
Wang SS, Liu YF, Ou YC, Chen CS, Li JR, Yang SF, 2013: Impacts of CA9 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan[J]. PLoS ONE, 8, e82804-. doi: 10.1371/journal.pone.0082804
-
Wang S, Wang J, Fan MJ, Li TY, Pan H, Wang X, Liu HK, Lin QF, Zhang JG, Guan LP, Zhernakova DV, O'Brien SJ, Feng ZR, Chang L, Dai EH, Lu JH, Xi HL, Zeng Z, Yu YY, Wang BB, 2018: Identified OAS3 gene variants associated with coexistence of HBsAg and anti-HBs in chronic HBV infection[J]. J Viral Hepat, 25, 904-910. doi: 10.1111/jvh.12899
-
WHO (2015) Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatits B Infection. https://www.who.int/hepatitis/publications/hepatitis-b-guidelines/en/
-
WHO (2017) GLOBAL HEPATITIS REPORT, 2017. https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/
-
Xia C, Lu M, Zhang Z, Meng Z, Zhang Z, Shi C, 2008: TLRs antiviral effect on hepatitis B virus in HepG2 cells[J]. J Appl Microbiol, 105, 1720-1727. doi: 10.1111/j.1365-2672.2008.03896.x
-
Xiang Y, Chen P, Xia JR, Zhang LP, 2017: A large-scale analysis study on the clinical and viral characteristics of hepatitis B infection with concurrence of hepatitis B surface or E antigens and their corresponding antibodies[J]. Genet Mol Res, , 16-.
-
Xiong W, Wang X, Liu X, Xiang L, Zheng L, Yuan Z, 2004: Interferon-inducible MyD88 protein inhibits hepatitis B virus replication[J]. Virology, 319, 306-314. doi: 10.1016/j.virol.2003.11.005
-
Yoo H, Sohn S, Nam BH, Min HS, Jung E, Shin SH, Gwak HS, Lee SH, 2010: The expressions of carbonic anhydrase 9 and vascular endothelial growth factor in astrocytic tumors predict a poor prognosis[J]. Int J Mol Med, 26, 3-9.
-
Zeng Z, 2014: Human genes involved in hepatitis B virus infection[J]. World J Gastroenterol, 20, 7696-7706. doi: 10.3748/wjg.v20.i24.7696
-
Zhang Q, Davis JC, Lamborn IT, Freeman AF, Jing H, Favreau AJ, Matthews HF, Davis J, Turner ML, Uzel G, Holland SM, Su HC, 2009: Combined immunodeficiency associated with DOCK8 mutations[J]. N Engl J Med, 361, 2046-2055. doi: 10.1056/NEJMoa0905506
-
Zhang TC, Pan FM, Zhang LZ, Gao YF, Zhang ZH, Gao J, Ge R, Mei Y, Shen BB, Duan ZH, Li X, 2011a: A meta-analysis of the relation of polymorphism at sites -1082 and -592 of the IL-10 gene promoter with susceptibility and clearance to persistent hepatitis B virus infection in the Chinese population[J]. Infection, 39, 21-27. doi: 10.1007/s15010-010-0075-3
-
Zhang X, Zhang E, Ma Z, Pei R, Jiang M, Schlaak JF, Roggendorf M, Lu M, 2011b: Modulation of hepatitis B virus replication and hepatocyte differentiation by MicroRNA-1[J]. Hepatology, 53, 1476-1485. doi: 10.1002/hep.24195
-
Zhang K, Pan X, Shu X, Cao H, Chen L, Zou Y, Deng H, Li G, Xu Q, 2013: Relationship between MIF-173 G/C polymorphism and susceptibility to chronic hepatitis B and HBV-induced liver cirrhosis[J]. Cell Immunol, 282, 113-116. doi: 10.1016/j.cellimm.2013.04.013
-
Zheng JX, Zeng Z, Zheng YY, Yin SJ, Zhang DY, Yu YY, Wang F, 2011: Role of hepatitis B virus base core and precore/core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients[J]. J Viral Hepat, 18, e423-431. doi: 10.1111/j.1365-2893.2011.01458.x
-
Zheng MH, Xiao DD, Lin XF, Wu SJ, Peng MM, Yu XY, Liu WY, Li LF, Shi KQ, Fan YC, Chen YP, 2012: The tumour necrosis factor-alpha-238A allele increases the risk of chronic HBV infection in European populations[J]. J Viral Hepat, 19, e11-17. doi: 10.1111/j.1365-2893.2011.01491.x
-
Zhou X, Stephens M, 2012: Genome-wide efficient mixed-model analysis for association studies[J]. Nat Genet, 44, 821-824. doi: 10.1038/ng.2310